ClinicalTrials.Veeva

Menu

LEICeSter Tendon Extracorporeal Shockwave Studies (LEICSTES)

NHS Trust logo

NHS Trust

Status

Enrolling

Conditions

Tendinopathy

Treatments

Other: structured rehabilitation programme
Device: Extra-Corporeal Shockwave Therapy (ESWT)

Study type

Interventional

Funder types

Other

Identifiers

NCT02546128
UHL - 11401

Details and patient eligibility

About

To assess whether the addition of Extra-corporeal Shockwave Therapy (ESWT) to a structured home-exercise programme has any additional benefit to patients with tendinopathies

Full description

This involves patients with one of 6 different defined chronic tendinopathies. These individual sites are run as discrete sub-studies, with randomisation n occurring within sub-study grouping

Enrollment

720 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients age >18

  2. Symptoms (typically pain / stiffness) of at least 12 weeks of one of the following sites / conditions:

    1. Plantar fasciitis
    2. Insertional Achilles tendinopathy
    3. Mid-substance Achilles tendinopathy
    4. Patella tendinopathy
    5. Trochanteric pain syndrome (gluteus medius insertional tendinopathy / trochanteric bursitis)
    6. Tennis elbow
  3. Referred for ESWT (shockwave) within the Sports Medicine Department

  4. Objective imaging of tendon / structure confirming diagnosis and excluding tear or other structural injury (US or MRI acceptable)

Exclusion criteria

  1. Patients with the normal exclusions for ESWT - including pre-existing skin injury over tendon site, recent steroid injection (within 6 weeks of ESWT starting), patients on anticoagulation, patients with haemophilia or other bleeding tendency, patients with current febrile illness
  2. Previous ESWT treatment for the same condition

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

720 participants in 2 patient groups, including a placebo group

intervention
Experimental group
Description:
rehabilitation + "active-dose" ESWT (extra-corporeal shockwave therapy)
Treatment:
Device: Extra-Corporeal Shockwave Therapy (ESWT)
Other: structured rehabilitation programme
control
Placebo Comparator group
Description:
rehabilitation + "placebo-dose" ESWT (extra-corporeal shockwave therapy)
Treatment:
Other: structured rehabilitation programme

Trial contacts and locations

1

Loading...

Central trial contact

Patrick Wheeler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems